Allopurinol
NDC Package 53002-4821-3

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Allopurinol is used to treat gout and certain types of kidney stones. Marketed by Rpk Pharmaceuticals, Inc., this product is identified by NDC 53002-4821 and is authorized under FDA application NDA018877.

Identification & Billing

NDC Package Code
53002-4821-3
Package Description
30 TABLET in 1 BOTTLE
Product Code
53002-4821
11-Digit Billing Format
53002482103
RxNorm Crosswalk
RxCUI: 197320 - allopurinol 300 MG Oral Tablet

Clinical Specifications

Proprietary Name
Allopurinol
Dosage Form
-
Usage Information
Allopurinol is used to treat gout and certain types of kidney stones. It is also used to prevent increased uric acid levels in patients receiving cancer chemotherapy. These patients can have increased uric acid levels due to release of uric acid from the dying cancer cells. Allopurinol works by reducing the amount of uric acid made by the body. Increased uric acid levels can cause gout and kidney problems.

Regulatory & Marketing

Labeler Name
Rpk Pharmaceuticals, Inc.
FDA Application #
NDA018877
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
04-06-2009
Listing Expiration
12-31-2024
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (53002-4821). Click a package code to view its specific billing and regulatory data.

53002-4821-0
100 TABLET in 1 BOTTLE
53002-4821-6
60 TABLET in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 53002-4821-3 identifies a specific commercial package of 30 tablet in 1 bottle of Allopurinol, labeled by Rpk Pharmaceuticals, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Rpk Pharmaceuticals, Inc. on April 06, 2009. The current certification is valid through December 31, 2024.

What are the primary indications for this medication?

Allopurinol is used to treat gout and certain types of kidney stones. It is also used to prevent increased uric acid levels in patients receiving cancer chemotherapy. These patients can have increased uric acid levels due to release of uric acid from the dying cancer cells. Allopurinol works by reducing the amount of uric acid made by the body. Increased uric acid levels can cause gout and kidney problems.

How is this Rpk Pharmaceuticals, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 53002482103. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
53002-4821-3
11-Digit CMS (5-4-2)
53002-4821-03

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.